Cargando…

Perceived high risk of COVID-19 vaccination: The revealing power of placebo

Detalles Bibliográficos
Autores principales:	Beyens, Michiel, Toscano, Alessandro, Van Damme, Pierre, Dogné, Jean-Michel, Ebo, Didier G., Sabato, Vito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2023
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036145/ https://www.ncbi.nlm.nih.gov/pubmed/36965707 http://dx.doi.org/10.1016/j.jaip.2023.03.031

Ejemplares similares

Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies
por: Toscano, Alessandro, et al.
Publicado: (2023)

Nonirritating skin test concentrations for ceftazidime and aztreonam in patients with a documented beta-lactam allergy
por: van der Poorten, Marie-Line M., et al.
Publicado: (2021)

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
por: Gillot, Constant, et al.
Publicado: (2021)

Basophil Activation Tests: A Diagnostic Break-Through in Opiate Allergy
por: Uyttebroek, Astrid, et al.
Publicado: (2015)

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
por: Favresse, Julien, et al.
Publicado: (2021)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

On the Antivariolous Power of Vaccination
por: Colville, G.
Publicado: (1818)

Protective Power of Vaccination
por: Noble, H.
Publicado: (1861)

Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals
por: Bayart, Jean-Louis, et al.
Publicado: (2023)

Protective and Modifying Powers of Vaccination
por: Seaton, Edward C.
Publicado: (1857)

Covid 19 vaccines and the misinterpretation of perceived side effects clarity on the safety of vaccines
por: Palmer, Raymond D.
Publicado: (2022)

Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection
por: Bizimungu, Christelle, et al.
Publicado: (2023)

O11 - Cor a 14: the missing link in the molecular diagnosis of hazelnut allergy?
por: Faber, Margaretha, et al.
Publicado: (2014)

Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant
por: Bayart, Jean-Louis, et al.
Publicado: (2022)

Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature review
por: Gossec, Laure, et al.
Publicado: (2014)

On the Protective Power of Vaccination as Influenced by Change of Climate
por: Harvey, Robert
Publicado: (1870)

Urticaria after COVID-19 vaccination and vaccine hesitancy
por: Judd, Allen, et al.
Publicado: (2023)

Placebo in Dental Practice
por: Henry, J. C.
Publicado: (1873)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Observations on the Protecting Power of Vaccination against Small-Pox
por: Stuart, John
Publicado: (1840)

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination
por: Robinson, Lacey B., et al.
Publicado: (2021)

Delayed cutaneous hypersensitivities to COVID-19 vaccination: Phenotypic distribution and tolerability of vaccine rechallenge
por: De Luca, Joseph F., et al.
Publicado: (2023)

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
por: Favresse, Julien, et al.
Publicado: (2021)

Short- and long-lasting tinnitus relief induced by transcranial direct current stimulation
por: Garin, Pierre, et al.
Publicado: (2011)

Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
por: Picard, Matthieu, et al.
Publicado: (2022)

Power Moves Beyond Complementarity: A Staring Look Elicits Avoidance in Low Power Perceivers and Approach in High Power Perceivers
por: Weick, Mario, et al.
Publicado: (2017)

COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated
por: Lazarinis, Nikolaos, et al.
Publicado: (2022)

Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review
por: Minet, Valentine, et al.
Publicado: (2017)

Hypothyroidism During Immune Checkpoint Inhibitor Therapy That Is Not Responsive to Thyroxin Substitution. A Peripheral T4-T3 Conversion Block?
por: Verelst, Faro, et al.
Publicado: (2021)

Placebo response in depression
por: Sonawalla, Shamsah B., et al.
Publicado: (2002)

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome
por: Gillot, Constant, et al.
Publicado: (2022)

COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema
por: Fijen, Lauré M., et al.
Publicado: (2021)

PECS I block for postoperative analgesia in patients undergoing breast augmentation surgery: a randomized double-blind placebo-controlled study()
por: Desroches, Jean, et al.
Publicado: (2020)

Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease
por: Zachariae, R, et al.
Publicado: (2003)

Power of Imagination
por: Hayes, P. H.
Publicado: (1872)

A Visible‐Light‐Powered Polymerization Method for the Immobilization of Enantioselective Organocatalysts into Microreactors
por: Warias, Rico, et al.
Publicado: (2020)

An Application of Machine Learning in Pharmacovigilance: Estimating Likely Patient Genotype From Phenotypical Manifestations of Fluoropyrimidine Toxicity
por: Correia Pinheiro, Luis, et al.
Publicado: (2020)

Safety of COVID-19 vaccination in patients with clonal mast cell disorders
por: Ruano-Zaragoza, Maria, et al.
Publicado: (2022)

Anaphylaxis after COVID-19 vaccination: A registry-based study
por: Jaggers, Jordon, et al.
Publicado: (2022)

Safety of COVID-19 mRNA vaccination in children with chronic urticaria
por: Zhu, Catherine K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ghbr51valrmatci5i88mgvfuie